Literature DB >> 20726461

Concise guidance: diagnosis and management of polymyalgia rheumatica.

Dasgupta Bhaskar1.   

Abstract

Polymyalgia rheumatica (PMR) is among the most common reasons for long-term steroid prescription with great heterogeneity in presentation, response to steroids and disease course. The British Society for Rheumatology and the British Health Professionals in Rheumatology have recently published guidelines on management of PMR. The purpose of this concise guidance is to draw attention to the full guidelines and provide a safe and specific diagnostic process with advice on management and monitoring--specifically targeted at general practitioners, general physicians and rheumatologists.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726461      PMCID: PMC5873556          DOI: 10.7861/clinmedicine.10-3-270

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  4 in total

1.  Polymyalgia rheumatica: the mess we are now in and what we need to do about it.

Authors:  Bhaskar Dasgupta; Andrew Hutchings; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2006-08-15

2.  BSR and BHPR guidelines for the management of polymyalgia rheumatica.

Authors:  Bhaskar Dasgupta; Frances A Borg; Nada Hassan; Kevin Barraclough; Brian Bourke; Joan Fulcher; Jane Hollywood; Andrew Hutchings; Valerie Kyle; Jennifer Nott; Michael Power; Ash Samanta
Journal:  Rheumatology (Oxford)       Date:  2009-11-12       Impact factor: 7.580

3.  An initially double-blind controlled 96 week trial of depot methylprednisolone against oral prednisolone in the treatment of polymyalgia rheumatica.

Authors:  B Dasgupta; A L Dolan; G S Panayi; L Fernandes
Journal:  Br J Rheumatol       Date:  1998-02

4.  Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.

Authors:  Andrew Hutchings; Jane Hollywood; Donna L Lamping; Colin T Pease; Kuntal Chakravarty; Barbara Silverman; Ernest H S Choy; David G I Scott; Brian L Hazleman; Brian Bourke; Nagui Gendi; Bhaskar Dasgupta
Journal:  Arthritis Rheum       Date:  2007-06-15
  4 in total
  7 in total

1.  An update on the general management approach to common vasculitides.

Authors:  Mooikhin Hng; Sizheng S Zhao; Robert J Moots
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

2.  The epidemiology of polymyalgia rheumatica in primary care: a research protocol.

Authors:  Sara Muller; Samantha Hider; Toby Helliwell; Joanne Bailey; Kevin Barraclough; Louise Cope; Bhaskar Dasgupta; Rebecca Foskett; Rhian Hughes; Zoe Mayson; Charlotte Purcell; Edward Roddy; Simon Wathall; Irena Zwierska; Christian D Mallen
Journal:  BMC Musculoskelet Disord       Date:  2012-06-15       Impact factor: 2.362

Review 3.  Retrospective analysis of the clinical course of patients treated for polymyalgia.

Authors:  Dung Do-Nguyen; Charles A Inderjeeth; Jack Edelman; Patrick Cheah
Journal:  Open Access Rheumatol       Date:  2013-04-24

4.  Use of multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to evaluate accuracy.

Authors:  Jessica Watson; Hayley E Jones; Jonathan Banks; Penny Whiting; Chris Salisbury; Willie Hamilton
Journal:  Br J Gen Pract       Date:  2019-06-17       Impact factor: 5.386

5.  Added value and cascade effects of inflammatory marker tests in UK primary care: a cohort study from the Clinical Practice Research Datalink.

Authors:  Jessica Watson; Chris Salisbury; Penny Whiting; Jonathan Banks; Yvette Pyne; Willie Hamilton
Journal:  Br J Gen Pract       Date:  2019-06-17       Impact factor: 5.386

6.  Balancing on the edge: implications of a UK national audit of the use of BSR-BHPR guidelines for the diagnosis and management of polymyalgia rheumatica.

Authors:  Parthajit Das; Ash Samanta; Bhaskar Dasgupta
Journal:  RMD Open       Date:  2015-07-28

7.  A case report of polymyalgia rheumatica.

Authors:  Iryna Kniazkova; Larysa Shapovalova; Maryna Bogun
Journal:  Reumatologia       Date:  2018-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.